The potential of lipid-polymer nanoparticles as epigenetic and ROS control approaches for COPD

References

• Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. Gold executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582.
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33(5):1165–1185.
   PubMed Web of Science ®Google Scholar
• Cavaillès A, Brinchault-Rabin G, Dixmier A, et al. Comorbidities of COPD. Eur Respir Rev. 2013;22(130):454–475.
   PubMedGoogle Scholar
• Soriano JB, Abajobir AA, Abate KH, GBD 2015 Chronic respiratory disease Collaborators, et al. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5:691–706.
   PubMed Web of Science ®Google Scholar
• Cosio MG, Saetta M, Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med. 2009;360(23):2445–2454.
   PubMed Web of Science ®Google Scholar
• Allen-Gipson DS, Zimmerman MC, Zhang H, et al. Smoke extract impairs adenosine wound healing: implications of smoke-generated reactive oxygen species. Am J Respir Cell Mol Biol. 2013;48(5):665–673.
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J. 2003;22(4):672–688.
   PubMed Web of Science ®Google Scholar
• Loukides S, Bakakos P, Kostikas K. Oxidative stress in patients with COPD. Curr Drug Targets. 2011;12(4):469–477.
   PubMed Web of Science ®Google Scholar
• Kasielski M, Nowak D. Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease. Respir Med. 2001;95(6):448–456.
   PubMed Web of Science ®Google Scholar
• Rahman I. Pharmacological antioxidant strategies as therapeutic interventions for COPD. Biochim Biophys Acta. 2012;1822(5):714–728.
   PubMed Web of Science ®Google Scholar
• de Oliveira-Marques V, Cyrne L, Marinho HS, et al. A quantitative study of NF-κB activation by H2O2: relevance in inflammation and synergy with TNF-α. J Immunol. 2007;178(6):3893–3902.
   PubMed Web of Science ®Google Scholar
• Boushey HA. Glucocorticoid therapy for chronic obstructive pulmonary disease. N Engl J Med. 1999;340(25):1990–1991.
   PubMed Web of Science ®Google Scholar
• Ito K, Yamamura S, Essilfie-Quaye S, et al. Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-κB suppression. J Exp Med. 2006;203(1):7–13.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Mechanisms and resistance in glucocorticoid control of inflammation. J Steroid Biochem Mol Biol. 2010;120(2-3):76–85.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2013;131(3):636–645.
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Adcock IM. Glucocorticoid resistance in inflammatory diseases. Lancet. 2009;373(9678):1905–1917.
   PubMed Web of Science ®Google Scholar
• Kadmiel M, Cidlowski JA. Glucocorticoid receptor signaling in health and disease. Trends Pharmacol Sci. 2013;34(9):518–530.
   PubMed Web of Science ®Google Scholar
• Delcuve GP, Khan DH, Davie JR. Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors. Clin Epigenetics. 2012;4(1):5.
   PubMed Web of Science ®Google Scholar
• Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res. 2011;21(3):381–395.
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Adcock IM, Ito K. Histone acetylation and deacetylation: importance in inflammatory lung diseases. Eur Respir J. 2005;25(3):552–563.
   PubMed Web of Science ®Google Scholar
• Shakespear MR, Halili MA, Irvine KM, et al. Histone deacetylases as regulators of inflammation and immunity. Trends Immunol. 2011;32(7):335–343.
   PubMed Web of Science ®Google Scholar
• Ito K, Ito M, Elliott WM, et al. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med. 2005;352(19):1967–1976.
   PubMed Web of Science ®Google Scholar
• Cosio BG, Tsaprouni L, Ito K, et al. Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages. J Exp Med. 2004;200(5):689–695.
   PubMed Web of Science ®Google Scholar
• van den Bosch T, Kwiatkowski M, Bischoff R, et al. Targeting transcription factor lysine acetylation in inflammatory airway diseases. Epigenomics. 2017;9(7):1013–1028.
   PubMed Web of Science ®Google Scholar
• Oostwoud LC, Gunasinghe P, Seow HJ, et al. Apocynin and ebselen reduce influenza A virus-induced lung inflammation in cigarette smoke-exposed mice. Sci Rep. 2016;6(1):20983.
   PubMed Web of Science ®Google Scholar
• Tanaka K, Ishihara T, Sugizaki T, et al. Mepenzolate bromide displays beneficial effects in a mouse model of chronic obstructive pulmonary disease. Nat Commun. 2013;4(1):2686.
   PubMedGoogle Scholar
• Leus NGJ, van der Wouden PE, van den Bosch T, et al. HDAC 3-selective inhibitor RGFP966 demonstrates anti-inflammatory properties in RAW 264.7 macrophages and mouse precision-cut lung slices by attenuating NF-κB p65 transcriptional activity. Biochem Pharmacol. 2016;108:58–74.
   PubMed Web of Science ®Google Scholar
• Lee BK, Yun Y, Park K. PLA micro- and nano-particles. Adv Drug Deliv Rev. 2016;107:176–191.
   PubMed Web of Science ®Google Scholar
• Hadinoto K, Sundaresan A, Cheow WS. Lipid–polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review. Eur J Pharm Biopharm. 2013;85(3):427–443.
   PubMed Web of Science ®Google Scholar
• Mandal B, Bhattacharjee H, Mittal N, et al. Core-shell-type lipid-polymer hybrid nanoparticles as a drug delivery platform. Nanomedicine. 2013;9(4):474–491.
   PubMed Web of Science ®Google Scholar
• Kubota R, Imamura S, Shimizu T, et al. Synthesis of water-soluble dinuclear Mn-porphyrin with multiple antioxidative activities. ACS Med Chem Lett. 2014;5(6):639–643.
   PubMed Web of Science ®Google Scholar
• Asaba Y, Asayama S, Kawakami H. Design of epigenetics control carrier for simultaneous transfection of histone acetyltransferase with histone deacetylase inhibitor to continuous histone acetylation. Polym J. 2016;48(5):561–564.
   Web of Science ®Google Scholar
• Troutier-Thuilliez A-L, Thevenot J, Delair T, et al. Adsorption of plasmid DNA onto lipid/polymer particle assemblies. Soft Matter. 2009;5(23):4739–4747.
   Web of Science ®Google Scholar
• Hara H, Kuwano K, Araya J. Mitochondrial quality control in COPD and IPF. Cells. 2018;7(8):86.
   PubMed Web of Science ®Google Scholar
• Ryter SW, Rosas IO, Owen CA, et al. Mitochondrial dysfunction as a pathogenic mediator of chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. Annals ATS. 2018;15(Supplement_4):S266–S272.
   Google Scholar
• Cloonan SM, Choi A. Mitochondria in lung disease. J Clin Invest. 2016;126(3):809–820.
   PubMed Web of Science ®Google Scholar
• James AM, Sharpley MS, Manas AR, et al. Interaction of the mitochondria-targeted antioxidant MitoQ with phospholipid bilayers and ubiquinone oxidoreductases. J Biol Chem. 2007;282(20):14708–14718.
   PubMed Web of Science ®Google Scholar
• James AM, Cochemé HM, Smith RAJ, et al. Interactions of mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species. Implications for the use of exogenous ubiquinones as therapies and experimental tools. J Biol Chem. 2005;280(22):21295–21312.
   PubMed Web of Science ®Google Scholar
• Chinopoulos C, Tretter L, Adam-Vizi V. Depolarization of in situ mitochondria due to hydrogen peroxide-induced oxidative stress in nerve terminals: inhibition of α-ketoglutarate dehydrogenase. J Neurochem. 2002;73(1):220–228.
   Google Scholar
• Cottet-Rousselle C, Ronot X, Leverve X, et al. Cytometric assessment of mitochondria using fluorescent probes. Cytometry. 2011;79(6):405–425.
   PubMedGoogle Scholar
• Reers M, Smith TW, Chen LB. J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. Biochemistry. 1991;30(18):4480–4486.
   PubMed Web of Science ®Google Scholar
• Perng DW, Su KC, Chou KT, et al. Long-acting β2 agonists and corticosteroids restore the reduction of histone deacetylase activity and inhibit H2O2-induced mediator release from alveolar macrophages. Pulm Pharmacol Ther. 2012;25(4):312–318.
   PubMed Web of Science ®Google Scholar
• Osoata GO, Yamamura S, Ito M, et al. Nitration of distinct tyrosine residues causes inactivation of histone deacetylase 2. Biochem Biophys Res Commun. 2009;384(3):366–371.
   PubMed Web of Science ®Google Scholar
• Chang LY, Crapo JD. Inhibition of airway inflammation and hyperreactivity by an antioxidant mimetic. Free Radic Biol Med. 2002;33(3):379–386.
   PubMed Web of Science ®Google Scholar
• Smith KR, Uyeminami DL, Kodavanti UP, et al. Inhibition of tobacco smoke-induced lung inflammation by a catalytic antioxidant. Free Radic Biol Med. 2002;33(8):1106–1114.
   PubMed Web of Science ®Google Scholar
• Zhang XR, Zhou WX, Zhang YX. Improvements in SOD mimic AEOL-10150, a potent broad-spectrum antioxidant. Mil Med Res. 2018;5(1):30.
   PubMedGoogle Scholar
• Haruyama T, Asayama S, Kawakami H. Highly amphiphilic manganese porphyrin for the mitochondrial targeting antioxidant. J Biochem. 2010;147(2):153–156.
   PubMed Web of Science ®Google Scholar